A detailed history of Wrapmanager Inc transactions in Biogen Inc. stock. As of the latest transaction made, Wrapmanager Inc holds 1,611 shares of BIIB stock, worth $279,975. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,611
Previous 2,078 22.47%
Holding current value
$279,975
Previous $448,000 16.74%
% of portfolio
0.1%
Previous 0.13%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$190.52 - $236.72 $88,972 - $110,548
-467 Reduced 22.47%
1,611 $373,000
Q1 2024

May 09, 2024

SELL
$212.02 - $267.71 $34,347 - $43,369
-162 Reduced 7.23%
2,078 $448,000
Q4 2023

Feb 07, 2024

SELL
$222.59 - $267.94 $42,737 - $51,444
-192 Reduced 7.89%
2,240 $579,000
Q3 2023

Nov 06, 2023

SELL
$253.3 - $285.89 $35,462 - $40,024
-140 Reduced 5.44%
2,432 $625,000
Q2 2023

Aug 08, 2023

SELL
$275.25 - $318.06 $60,279 - $69,655
-219 Reduced 7.85%
2,572 $732,000
Q1 2023

May 08, 2023

SELL
$256.56 - $292.34 $12,828 - $14,616
-50 Reduced 1.76%
2,791 $775,000
Q4 2022

Feb 06, 2023

SELL
$252.44 - $306.72 $73,964 - $89,868
-293 Reduced 9.35%
2,841 $787,000
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $54,123 - $74,631
-278 Reduced 8.15%
3,134 $837,000
Q2 2022

Aug 05, 2022

SELL
$187.54 - $223.02 $65,639 - $78,057
-350 Reduced 9.3%
3,412 $696,000
Q1 2022

May 10, 2022

BUY
$193.77 - $244.14 $130,988 - $165,038
676 Added 21.91%
3,762 $792,000
Q4 2021

Feb 07, 2022

SELL
$223.92 - $287.77 $210,708 - $270,791
-941 Reduced 23.37%
3,086 $740,000
Q3 2021

Nov 10, 2021

SELL
$282.99 - $369.05 $18,394 - $23,988
-65 Reduced 1.59%
4,027 $1.14 Million
Q2 2021

Aug 04, 2021

BUY
$259.0 - $414.71 $8,547 - $13,685
33 Added 0.81%
4,092 $1.42 Million
Q1 2021

May 10, 2021

BUY
$242.95 - $284.63 $74,828 - $87,666
308 Added 8.21%
4,059 $1.14 Million
Q4 2020

Feb 08, 2021

SELL
$236.26 - $355.63 $130,651 - $196,663
-553 Reduced 12.85%
3,751 $918,000
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $36,803 - $42,493
-139 Reduced 3.13%
4,304 $1.22 Million
Q2 2020

Aug 11, 2020

SELL
$258.66 - $342.55 $117,690 - $155,860
-455 Reduced 9.29%
4,443 $1.19 Million
Q1 2020

May 08, 2020

SELL
$268.85 - $341.04 $212,122 - $269,080
-789 Reduced 13.87%
4,898 $1.55 Million
Q4 2019

Feb 11, 2020

SELL
$220.06 - $304.07 $81,862 - $113,114
-372 Reduced 6.14%
5,687 $1.69 Million
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $60,448 - $67,798
-278 Reduced 4.39%
6,059 $1.41 Million
Q2 2019

Jul 31, 2019

SELL
$219.29 - $241.72 $34,428 - $37,950
-157 Reduced 2.42%
6,337 $1.48 Million
Q1 2019

May 06, 2019

SELL
$216.71 - $338.96 $32,289 - $50,505
-149 Reduced 2.24%
6,494 $1.54 Million
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $44,281 - $56,087
-159 Reduced 2.34%
6,643 $2 Million
Q3 2018

Nov 13, 2018

BUY
$293.51 - $383.83 $12,033 - $15,737
41 Added 0.61%
6,802 $2.4 Million
Q2 2018

Aug 03, 2018

BUY
$257.52 - $306.91 $309,539 - $368,905
1,202 Added 21.62%
6,761 $1.96 Million
Q1 2018

May 03, 2018

SELL
$260.13 - $367.91 $3,121 - $4,414
-12 Reduced 0.22%
5,559 $1.52 Million
Q4 2017

Feb 02, 2018

SELL
$307.64 - $344.58 $40,300 - $45,139
-131 Reduced 2.3%
5,571 $1.78 Million
Q3 2017

Nov 03, 2017

BUY
$281.15 - $329.69 $1.6 Million - $1.88 Million
5,702
5,702 $1.79 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.